RELMADA THERAPEUTICS, INC. — Director's Dealing 2015

Dec 16, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2015-12-14

Reporting Person: SETH SANDESH (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-14	Common stock	P	800	$2.50	Acquired	104058	Direct
2015-12-14	Common stock	P	140	$2.50	Acquired	104198	Direct
2015-12-14	Common stock	P	1560	$2.89	Acquired	105758	Direct
2015-12-14	Common stock	P	500	$2.90	Acquired	106258	Direct
2015-12-14	Common stock	P	1000	$2.97	Acquired	107258	Direct
2015-12-14	Common stock	P	5000	$2.99	Acquired	112258	Direct
2015-12-14	Common stock	P	1500	$3.00	Acquired	113758	Direct